Irbesartan and Hydrochlorothiazide (Teva Pharmaceuticals USA Inc)
Welcome to the PulseAid listing for the Irbesartan and Hydrochlorothiazide drug offered from Teva Pharmaceuticals USA Inc. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA Inc |
| NON-PROPRIETARY NAME: | Irbesartan and Hydrochlorothiazide |
| SUBSTANCE NAME: | IRBESARTAN; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-08-27 |
| END MARKETING DATE: | 0000-00-00 |
Irbesartan and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Irbesartan and Hydrochlorothiazide from Teva Pharmaceuticals USA Inc |
| LABELER NAME: | Teva Pharmaceuticals USA Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300; 12.5(mg/1; mg/1) |
| START MARKETING DATE: | 2013-08-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-8232_690e6c03-38b5-437f-bff2-34033934a35a |
| PRODUCT NDC: | 0093-8232 |
| APPLICATION NUMBER: | ANDA077369 |
Other IRBESARTAN; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
